It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
White matter hyperintensities index structural abnormalities in the cerebral white matter, including axonal damage. The latter may promote atrophy of the cerebral cortex, a key feature of dementia. Here, we report a study of 51,065 individuals from 10 cohorts demonstrating that higher white matter hyperintensity volume associates with lower cortical thickness. The meta-GWAS of white matter hyperintensities-associated cortical ‘atrophy’ identifies 20 genome-wide significant loci, and enrichment in genes specific to vascular cell types, astrocytes, and oligodendrocytes. White matter hyperintensities-associated cortical ‘atrophy’ showed positive genetic correlations with vascular-risk traits and plasma biomarkers of neurodegeneration, and negative genetic correlations with cognitive functioning. 15 of the 20 loci regulated the expression of 54 genes in the cerebral cortex that, together with their co-expressed genes, were enriched in biological processes of axonal cytoskeleton and intracellular transport. The white matter hyperintensities-cortical thickness associations were most pronounced in cortical regions with higher expression of genes specific to excitatory neurons with long-range axons traversing through the white matter. The meta-GWAS-based polygenic risk score predicts vascular and all-cause dementia in an independent sample of 500,348 individuals. Thus, the genetics of white matter hyperintensities-related cortical atrophy involves vascular and neuronal processes and increases dementia risk.
White matter hyperintensities are linked to cortical atrophy, a key feature in dementia. Here, the authors identify loci associated with cortical atrophy related to white matter hyperintensities, which involve vascular and neuronal processes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details























1 Toronto, The Hospital for Sick Children, Ontario, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); Toronto, Departments of Physiology and Nutritional Sciences, University of Toronto, Ontario, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938)
2 University of Oulu, Research Unit of Population Health, Faculty of Medicine, Oulu, Finland (GRID:grid.10858.34) (ISNI:0000 0001 0941 4873)
3 UMR1219, University of Bordeaux, INSERM, Bordeaux Population Health research center, Bordeaux, France (GRID:grid.412041.2) (ISNI:0000 0001 2106 639X)
4 The University of Texas Health Science Center at Houston, The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, Houston, USA (GRID:grid.267308.8) (ISNI:0000 0000 9206 2401)
5 Statistik und Dokumentation, Institut für Medizinische Informatik, Graz, Austria (GRID:grid.5110.5) (ISNI:0000000121539003); Medical University of Graz, Division of Neurogeriatrics, Department of Neurology, Graz, Austria (GRID:grid.11598.34) (ISNI:0000 0000 8988 2476)
6 Boston University School of Public Health, Department of Biostatistics, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558)
7 UMR1219, University of Bordeaux, INSERM, Bordeaux Population Health research center, Bordeaux, France (GRID:grid.412041.2) (ISNI:0000 0001 2106 639X); Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (GRID:grid.419524.f) (ISNI:0000 0001 0041 5028)
8 Statistics and Epidemiology; Leipzig University, Institute for Medical Informatics, Leipzig, Germany (GRID:grid.9647.c) (ISNI:0000 0004 7669 9786)
9 Erasmus MC University Medical Center Rotterdam, Department of Epidemiology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:0000 0004 0459 992X); Erasmus MC University Medical Center Rotterdam, Department of Radiology and Nuclear Medicine, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:0000 0004 0459 992X)
10 University Medicine Greifswald, Institute for Community Medicine, Greifswald, Germany (GRID:grid.412469.c) (ISNI:0000 0000 9116 8976)
11 University Medicine Greifswald, Institute of Diagnostic Radiology and Neuroradiology, Greifswald, Germany (GRID:grid.412469.c) (ISNI:0000 0000 9116 8976)
12 University Medicine Greifswald, Interfaculty Institute of Genetics and Functional Genomics, Greifswald, Germany (GRID:grid.412469.c) (ISNI:0000 0000 9116 8976)
13 University Medicine Greifswald, Department of Psychiatry and Psychotherapy, Greifswald, Germany (GRID:grid.412469.c) (ISNI:0000 0000 9116 8976)
14 University Medicine Greifswald, Department of Psychiatry and Psychotherapy, Greifswald, Germany (GRID:grid.412469.c) (ISNI:0000 0000 9116 8976); Site Rostock/Greifswald, German Centre for Neurodegenerative Diseases (DZNE), Greifswald, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426)
15 The University of Mississippi Medical Center, The MIND Center, Jackson, USA (GRID:grid.410721.1) (ISNI:0000 0004 1937 0407)
16 UMR1219, University of Bordeaux, INSERM, Bordeaux Population Health research center, Bordeaux, France (GRID:grid.412041.2) (ISNI:0000 0001 2106 639X); Pôle Santé Publique, CHU Bordeaux, CIC 1401 EC, Bordeaux, France (GRID:grid.42399.35) (ISNI:0000 0004 0593 7118)
17 University of Lille, U1167-RID-AGE facteurs de risque et déterminants moléculaires des maladies liées au vieillissement, INSERM, CHU Lille, Institut Pasteur de Lille, Lille, France (GRID:grid.503422.2) (ISNI:0000 0001 2242 6780)
18 UMR1219, University of Bordeaux, INSERM, Bordeaux Population Health research center, Bordeaux, France (GRID:grid.412041.2) (ISNI:0000 0001 2106 639X); CHU de Bordeaux, Department of Public Health, Bordeaux, France (GRID:grid.42399.35) (ISNI:0000 0004 0593 7118)
19 Baobab, Université Paris-Saclay, CEA, CNRS, Neurospin, Saclay, France (GRID:grid.460789.4) (ISNI:0000 0004 4910 6535)
20 National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, USA (GRID:grid.416870.c) (ISNI:0000 0001 2177 357X)
21 Medical University of Graz, Division of Neurogeriatrics, Department of Neurology, Graz, Austria (GRID:grid.11598.34) (ISNI:0000 0000 8988 2476)
22 Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (GRID:grid.419524.f) (ISNI:0000 0001 0041 5028)
23 Statistics and Epidemiology; Leipzig University, Institute for Medical Informatics, Leipzig, Germany (GRID:grid.9647.c) (ISNI:0000 0004 7669 9786); Leipzig Research Centre for Civilization Diseases; Leipzig University, Leipzig, Germany (GRID:grid.9647.c) (ISNI:0000 0004 7669 9786)
24 Erasmus MC University Medical Center Rotterdam, Department of Epidemiology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:0000 0004 0459 992X)
25 University Medicine Greifswald, Interfaculty Institute of Genetics and Functional Genomics, Greifswald, Germany (GRID:grid.412469.c) (ISNI:0000 0000 9116 8976); University Medicine Greifswald, Department of Psychiatry and Psychotherapy, Greifswald, Germany (GRID:grid.412469.c) (ISNI:0000 0000 9116 8976)
26 University of Texas, San Antonio, USA (GRID:grid.215352.2) (ISNI:0000 0001 2184 5633)
27 UMR1219, University of Bordeaux, INSERM, Bordeaux Population Health research center, Bordeaux, France (GRID:grid.412041.2) (ISNI:0000 0001 2106 639X); Institute for Neurodegenerative Diseases, Bordeaux University Hospital, Department of Neurology, Bordeaux, France (GRID:grid.42399.35) (ISNI:0000 0004 0593 7118)
28 University of Montreal, Centre hospitalier universitaire Sainte-Justine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357); University of Montreal, Departments of Psychiatry and Neuroscience, Faculty of Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136); McGill University, Department of Psychiatry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); ECOGENE-21, Chicoutimi, Canada (GRID:grid.14709.3b)
29 Toronto, The Hospital for Sick Children, Ontario, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); Toronto, Departments of Physiology and Nutritional Sciences, University of Toronto, Ontario, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); University of Montreal, Centre hospitalier universitaire Sainte-Justine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357); ECOGENE-21, Chicoutimi, Canada (GRID:grid.14848.31); University of Montreal, Department of Pediatrics, Faculty of Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136)